Sammenlign metoder
Gjennomgå de valgte metodene side om side; rader som avviker, er uthevet.
| Morisky Medication Adherence Scale (MMAS)× | Klinisk skjørhets-skala (KSS)× | |
|---|---|---|
| Fagfelt | Sykepleie | Sykepleie |
| Familie | Process / pipeline | Process / pipeline |
| Opprinnelsesår≠ | 1986 | 2005 |
| Opphavsperson≠ | Donald E. Morisky | Kenneth Rockwood |
| Type≠ | Patient self-report questionnaire | Clinician-rated frailty assessment |
| Opprinnelig kilde≠ | Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 24(1), 67-74. DOI ↗ | Rockwood, K., Song, X., MacKnight, C., et al. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ, 173(5), 489-495. DOI ↗ |
| Alias | MMAS, Morisky Scale, Medication Adherence Scale | CFS, Frailty Scale, Clinical Frailty Assessment |
| Relaterte≠ | 2 | 3 |
| Sammendrag≠ | The Morisky Medication Adherence Scale is a brief, validated tool developed by Donald Morisky in 1986 to measure patients' adherence to prescribed medications. Originally created to assess hypertension medication compliance, it has since become a standard screening instrument across chronic disease management, primary care, and pharmaceutical research. The scale is valued for its brevity, ease of administration, and predictive validity for clinical outcomes. | The Clinical Frailty Scale (CFS), developed by Kenneth Rockwood and colleagues in 2005, is a brief, validated tool for assessing frailty in older adults. Frailty—a syndrome of diminished physiologic reserve, increased vulnerability, and reduced functional ability—is recognized as a distinct clinical state that predicts mortality, disability, and healthcare utilization independent of age and comorbidities. The CFS uses a seven-point (or nine-point in later versions) clinical judgment-based scale, making it practical and rapid for bedside use in hospitals, clinics, and long-term care. |
| ScholarGateDatasett ↗ |
|
|